Conditions: Hypercholesterolemia
Keywords: Bioqeuivalence, Pharmacokinetics, Atorvastatin
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 76
Healthy volunteers: yes

Brief summary:
To determine whether new 80 mg atorvastatin tablets are bioequivalent to 80 mg commercial atorvastatin tablets (Lipitor®).

Detailed description:

Arms:
arm 1: 80 mg atorvastatin tablets arm 2: New 80 mg atorvastatin tablets

Interventions: intervention 1: Atorvastatin intervention 2: Atorvastatin
Intervention descriptions: intervention 1: A single 80 mg dose of marketed 80 mg atorvastatin tablets intervention 2: A single dose of new formulation of 80 mg atorvastatin tablets

Protocol document: